Shelton Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-791
| Closed | -$8.34K | – | 740 |
|
|
2023
Q1 | $8.34K | Hold |
791
| – | – | ﹤0.01% | 722 |
|
|
2022
Q4 | $26.8K | Hold |
791
| – | – | ﹤0.01% | 675 |
|
|
2022
Q3 | $38K | Hold |
791
| – | – | ﹤0.01% | 681 |
|
|
2022
Q2 | $45K | Hold |
791
| – | – | ﹤0.01% | 708 |
|
|
2022
Q1 | $64K | Buy |
791
+108
| +16% | +$8.74K | ﹤0.01% | 791 |
|
|
2021
Q4 | $138K | Hold |
683
| – | – | ﹤0.01% | 819 |
|
|
2021
Q3 | $184K | Hold |
683
| – | – | 0.01% | 780 |
|
|
2021
Q2 | $176K | Hold |
683
| – | – | 0.01% | 806 |
|
|
2021
Q1 | $205K | Hold |
683
| – | – | 0.01% | 761 |
|
|
2020
Q4 | $174K | Hold |
683
| – | – | 0.01% | 692 |
|
|
2020
Q3 | $170K | Hold |
683
| – | – | 0.01% | 703 |
|
|
2020
Q2 | $237K | Sell |
683
-32
| -4% | -$11.1K | 0.01% | 520 |
|
|
2020
Q1 | $192K | Sell |
715
-57
| -7% | -$15.3K | 0.01% | 544 |
|
|
2019
Q4 | $250K | Buy |
+772
| New | +$250K | 0.01% | 624 |
|
|
2018
Q1 | – | Sell |
-930
| Closed | -$833K | – | 873 |
|
|
2017
Q4 | $833K | Hold |
930
| – | – | 0.05% | 259 |
|
|
2017
Q3 | $335K | Sell |
930
-89
| -9% | -$32.1K | 0.02% | 509 |
|
|
2017
Q2 | $299K | Buy |
1,019
+113
| +12% | +$33.2K | 0.02% | 574 |
|
|
2017
Q1 | $319K | Buy |
906
+160
| +21% | +$56.3K | 0.02% | 541 |
|
|
2016
Q4 | $137K | Hold |
746
| – | – | 0.01% | 846 |
|
|
2016
Q3 | $192K | Hold |
746
| – | – | 0.02% | 749 |
|
|
2016
Q2 | $159K | Hold |
746
| – | – | 0.01% | 734 |
|
|
2016
Q1 | $154K | Buy |
746
+69
| +10% | +$14.2K | 0.01% | 730 |
|
|
2015
Q4 | $171K | Hold |
677
| – | – | 0.02% | 708 |
|
|
2015
Q3 | $111K | Buy |
+677
| New | +$111K | 0.01% | 724 |
|